Literature DB >> 10585981

A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention-deficit/hyperactivity disorder.

W E Pelham1, E M Gnagy, A M Chronis, L Burrows-MacLean, G A Fabiano, A N Onyango, D L Meichenbaum, A Williams, H R Aronoff, R L Steiner.   

Abstract

OBJECTIVE: 1) To compare standard twice-daily methylphenidate (MPH) dosing with a single morning dose of MPH and of Adderall during a typical school-day time period, and 2) to conduct a dose-response study of the effects of a late-afternoon (3:30 PM) dose of MPH and Adderall on evening behavior and side effects.
DESIGN: Within-subject, placebo-controlled, crossover design.
SETTING: Intensive summer treatment program with a comprehensive behavioral approach. STUDY PARTICIPANTS: Twenty-one children with attention-deficit/hyperactivity disorder (19 boys and 2 girls), between the ages of 6 and 12 years.
INTERVENTIONS: Children received, in random order with daily crossovers, each of the following conditions: 1) placebo, 2) 0.3 mg/kg of MPH received 3 times, 3) 0.3 mg/kg of MPH received twice (7:30 AM and 11:30 AM) with 0.15 mg/kg received at 3:30 PM, 4) 0.3 mg/kg of MPH received once in the morning only, 5) 0.3 mg/kg of Adderall received at 7:30 AM and at 3:30 PM, 6) 0.3 mg/kg of Adderall once in the morning with 0.15 mg/kg received at 3:30 PM, 7) 0.3 mg/kg of Adderall received in the morning only. OUTCOME MEASURES: Daily rates of behaviors in social and academic settings, and standardized ratings from counselors and teachers, were assessed for the hours between 8:00 AM and 3:30 PM (a typical school-day). Relative sizes of the medication effects were compared hourly between first daily ingestion (7:30 AM) and 4:45 PM to assess the time course of the 2 drugs. Effects of the 3:30 PM doses on functioning in the evenings at home were evaluated using parent ratings of behavioral and side effects.
RESULTS: A single morning dose of Adderall produced equivalent behavioral effects to those of MPH received twice-daily and behavioral effects of that single morning dose lasted throughout the school-day period. One morning dose of MPH was less effective than either 2 daily doses of MPH or 1 dose of Adderall, and seemed to wear off in the early to mid-afternoon. For some children a single morning dose of MPH maintained their behavior for an entire school day in the context of the summer treatment program. On parent ratings of evening behavior, 0.3 mg/kg of MPH at 3:30 PM was superior to 0.15 mg/kg at 3:30 PM, but there was no difference between the 2 doses of Adderall. Compared with placebo at 3:30 PM, only the 0.3 mg/kg dose of MPH caused significant improvement in parent ratings. In placebo versus Adderall comparisons, all doses, even the condition that consisted of Adderall in the morning and placebo at 3:30 PM, produced a significant change in evening behavior.
CONCLUSIONS: The results show that, at least in the context of an intensive behavioral intervention, a single morning dose of Adderall had behavioral effects throughout an entire school day period that were equivalent to standard twice-daily MPH dosing. These results indicate that Adderall may be used as a long-acting stimulant for children for whom midday dosing is a problem. Further study including dose-response comparisons, effects in regular school settings, and direct comparisons with comparable doses of MPH and d-amphetamine will help to clarify the time course and relative advantages of Adderall.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10585981     DOI: 10.1542/peds.104.6.1300

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  33 in total

Review 1.  Interventions to address the academic impairment of children and adolescents with ADHD.

Authors:  Veronica L Raggi; Andrea M Chronis
Journal:  Clin Child Fam Psychol Rev       Date:  2006-06

2.  Cardiac safety of methylphenidate versus amphetamine salts in the treatment of ADHD.

Authors:  Almut Gertrud Winterstein; Tobias Gerhard; Jonathan Shuster; Arwa Saidi
Journal:  Pediatrics       Date:  2009-07       Impact factor: 7.124

3.  The Effects of Stimulant Medication and Training on Sports Competence Among Children With ADHD.

Authors:  Amy R Altszuler; Anne S Morrow; Brittany M Merrill; Shannon Bressler; Fiona L Macphee; Elizabeth M Gnagy; Andrew R Greiner; Stefany Coxe; Joseph S Raiker; Erika Coles; William E Pelham
Journal:  J Clin Child Adolesc Psychol       Date:  2017-01-19

Review 4.  Efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents: a network meta-analysis.

Authors:  Sarah C O S Padilha; Suzane Virtuoso; Fernanda S Tonin; Helena H L Borba; Roberto Pontarolo
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-02-19       Impact factor: 4.785

5.  Physical exercise alleviates ADHD symptoms: regional deficits and development trajectory.

Authors:  Trevor Archer; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2011-08-18       Impact factor: 3.911

Review 6.  A Review of the Clinical Utility of Systematic Behavioral Observations in Attention Deficit Hyperactivity Disorder (ADHD).

Authors:  Franziska Minder; Agnieszka Zuberer; Daniel Brandeis; Renate Drechsler
Journal:  Child Psychiatry Hum Dev       Date:  2018-08

7.  Correspondence of parent and teacher reports in medication trials.

Authors:  Stephen V Faraone; Joseph Biederman; Brenda Zimmerman
Journal:  Eur Child Adolesc Psychiatry       Date:  2005-02       Impact factor: 4.785

8.  Comparative efficacy of once-a-day extended-release methylphenidate, two-times-daily immediate-release methylphenidate, and placebo in a laboratory school setting.

Authors:  Manfred Döpfner; Wolff Dieter Gerber; Tobias Banaschewski; Dieter Breuer; Franz Joseph Freisleder; Gabi Gerber-von Müller; Michael Günter; Frank Hässler; Claudia Ose; Aribert Rothenberger; Klaus Schmeck; Judith Sinzig; Christina Stadler; Henrik Uebel; Gerd Lehmkuhl
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

Review 9.  Impact of Attention-Deficit Hyperactivity Disorder on School Performance: What are the Effects of Medication?

Authors:  Raman Baweja; Richard E Mattison; James G Waxmonsky
Journal:  Paediatr Drugs       Date:  2015-12       Impact factor: 3.022

Review 10.  Psychopharmacological and other treatments in preschool children with attention-deficit/hyperactivity disorder: current evidence and practice.

Authors:  Jaswinder K Ghuman; L Eugene Arnold; Bruno J Anthony
Journal:  J Child Adolesc Psychopharmacol       Date:  2008-10       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.